SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Neuland Laboratories reports two-fold rise in Q4 net profit

03 May 2012 Evaluate

Neuland Laboratories has reported results for fourth quarter ended March 31, 2012.

On the standalone basis, the company has posted a rise of 108.96% in its net profit at Rs 5.83 crore for the quarter ended March 31, 2012 as compared to Rs 2.79 crore for the same quarter in the previous year.  Total income has increased by 2.35% at Rs 113.04 crore for quarter under review as compared to Rs 110.45 crore for the quarter ended March 31, 2011

Neuland Laboratories Share Price

15376.90 169.00 (1.11%)
21-Apr-2026 10:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1670.05
Dr. Reddys Lab 1223.90
Cipla 1230.70
Zydus Lifesciences 929.55
Lupin 2325.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×